Intellia Therapeutics, Inc.
NTLA
$9.52
-$2.80-22.73%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -8.75% | -16.25% | -8.60% | -4.77% | -12.67% |
| Total Receivables | 8.08% | 23.33% | -3.81% | -28.19% | -66.15% |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -32.85% | 24.50% | -32.10% | -18.36% | -4.45% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | -10.06% | -13.83% | -9.99% | -6.12% | -14.35% |
|
|
|||||
| Total Current Assets | -10.06% | -13.83% | -9.99% | -6.12% | -14.35% |
| Net Property, Plant & Equipment | -6.90% | -33.88% | 91.08% | -4.86% | -4.78% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 24.30% | 150.50% | 3.31% | 0.10% | -4.37% |
| Total Assets | -8.85% | -17.20% | 1.51% | -1.53% | -5.40% |
|
|
|||||
| Total Accounts Payable | -20.72% | -15.25% | 10.99% | -30.14% | 37.45% |
| Total Accrued Expenses | 1.83% | -26.28% | 11.03% | 16.49% | 8.96% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -30.37% | 91.46% | 5.57% | 1.13% | 1.07% |
| Total Finance Division Other Current Liabilities | -16.97% | 0.00% | -12.10% | -4.11% | -6.37% |
| Total Other Current Liabilities | -16.97% | 0.00% | -12.10% | -4.11% | -6.37% |
| Total Current Liabilities | -15.18% | 1.57% | 4.89% | 0.56% | 7.33% |
|
|
|||||
| Total Current Liabilities | -15.18% | 1.57% | 4.89% | 0.56% | 7.33% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -6.07% | -57.63% | 130.40% | -5.59% | -5.18% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -4.73% | -27.91% | -19.25% | -19.41% | -16.11% |
| Total Liabilities | -10.96% | -35.36% | 51.40% | -4.42% | -1.33% |
|
|
|||||
| Common Stock & APIC | 1.20% | 0.72% | 1.36% | 4.26% | 2.93% |
| Retained Earnings | -4.42% | -5.25% | -6.29% | -7.09% | -8.32% |
| Treasury Stock & Other | -38.22% | 74.71% | -81.65% | 385.45% | -21.96% |
| Total Common Equity | -8.29% | -10.56% | -9.42% | -0.87% | -6.28% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -8.29% | -10.56% | -9.42% | -0.87% | -6.28% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -8.29% | -10.56% | -9.42% | -0.87% | -6.28% |
|
|
|||||